Cartesian Therapeutics, Inc. (RNAC) stock
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.08−0.27 (-4.25%)
Close on Nov 16, 2026Market cap $183.95MP/E –Yield –
Cartesian Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cartesian Therapeutics's market cap was $206.96M on Nov 10, 2026, against $194.77M a year earlier. Over the last 5 years it ranged from $89.91M to $485.46M, with a median of $209.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $206.96M | +10.4% |
| 2025 | Dec 31, 2025 | $187.49M | -56.2% |
| 2024 | Dec 31, 2024 | $427.99M | +301.1% |
| 2023 | Dec 29, 2023 | $106.69M | -38.3% |
| 2022 | Dec 30, 2022 | $172.92M | -54.1% |
| 2021 | Dec 31, 2021 | $376.35M | +15.8% |
| 2020 | Dec 31, 2020 | $324.93M | +183.3% |
| 2019 | Dec 31, 2019 | $114.71M | +92.5% |
| 2018 | Dec 31, 2018 | $59.57M | -72.5% |
| 2017 | Dec 29, 2017 | $217.00M | -30.4% |
| 2016 | Dec 30, 2016 | $311.93M | – |
See a number that looks wrong?